Editorial: Targeting the microbiota to attenuate chronic inflammation

Front Immunol. 2023 Apr 18:14:1202222. doi: 10.3389/fimmu.2023.1202222. eCollection 2023.

Elena Moreno^{1

2}, Marius Trøseid³, Ivan Vujkovic-Cvijin⁴, Giulia Marchetti⁵, Laura Martín-Pedraza^{1

2}, Sergio Serrano-Villar^{1

2}

¹ Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
² Centro de Investigación Biomédica En Red (CIBER) de Enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
³ Section for Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
⁴ Department of Biomedical Sciences & F. Widjaja Inflammatory Bowel Disease Institute, Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
⁵ Clinic of Infectious Diseases, Department of Health Sciences, University of Milan, ASST Santi Paolo e Carlo, Milan, Italy.

No abstract available

Keywords: biomarkers; inflammation; microbiota; omics; personalized medicine (PM).

Publication types